CollPlant Biotechnologies Ltd.
CLGN
|
$5.26
1.15%
-0.19%
4.3K
|
Health Technology
(0.0% 1d) (0.2% 1m) (-25.4% 1y) (0.0% 2d) (0.0% 3d) (1.2% 7d) (247.72% volume)
Earnings Calendar: 2024-03-29
Market Cap: $ 60,241,055
http://www.collplant.com
Sec Filling | Patents | 46 employees
(IL) CollPlant Biotechnologies Ltd. is a regenerative medicine company, which engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. The company's products include VergenixSTR, VergenixFG, and CollPlant Surgical Matrix. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
israel aesthetic
add to watch list Paper trade email alert is off
Press-releases
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
Published: 2024-04-04 (Crawled : 20:00) - biospace.com/
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -2.95%
biotechnologies year update financial results
COLLPLANT BIOTECHNOLOGIES REPORTS 2023 FULL YEAR FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE - April 4, 2024
Published: 2024-04-04 (Crawled : 12:30) - biospace.com/
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -2.95%
biotechnologies year update financial results
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 FULL YEAR FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Published: 2024-03-26 (Crawled : 12:00) - prnewswire.com
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: 3.72%
H: 0.0%
C: -3.77%
conference biotechnologies year financial results
3D Bio-Printing Industry to Surpass a Valuation of US$ 6.82 billion By 2034. Players to Capitalize on the Rising Demand for 3D Bio-printing during the Forecast Period
Published: 2024-01-24 (Crawled : 22:00) - prnewswire.com
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: -2.57%
H: 0.38%
C: -2.45%
CollPlant's CEO to Present at the Octane Aesthetic Tech Forum Conference, in Newport Beach, California
Published: 2024-01-08 (Crawled : 12:30) - prnewswire.com
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: 1.3%
H: 0.0%
C: -1.28%
california ceo aesthetic
CollPlant Biotechnologies Begins Preclinical Trial with Commercial-Size, Regenerative Breast Implants
Published: 2024-01-02 (Crawled : 12:00) - prnewswire.com
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: -2.82%
H: 6.6%
C: -2.58%
biotechnologies breast preclinical trial
Tissue Engineering Market worth $8.9 billion - Exclusive Report by MarketsandMarkets™
Published: 2023-12-18 (Crawled : 15:30) - prnewswire.com
SNNUF | $12.08 1.26% -1.12% 44
|
Health Technology
|
| O: 0.87%
H: 0.0%
C: -1.79%
TRUMF | $16.488 -1.51% -17.59% 1.7K
|
Health Technology
|
| O: -3.31%
H: 3.79%
C: -0.1%
TRUMY | $16.94 3.1% 0.79% 51K
|
Manufacturing
|
| O: 0.4%
H: 0.18%
C: 0.0%
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: -0.46%
H: 0.79%
C: 0.15%
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: -0.68%
H: 0.89%
C: 0.27%
VCEL | $45.38 3.75% 3.72% 300K
|
Health Technology
|
| O: -0.41%
H: 1.01%
C: -6.49%
MDXG | $6.36 1.11% 1.41% 2
|
Health Technology
|
| O: 0.33%
H: 1.56%
C: -2.22%
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: -3.07%
H: 2.17%
C: 0.79%
report market
CollPlant Biotechnologies Announces Third Quarter Financial Results for 2023
Published: 2023-11-29 (Crawled : 12:00) - prnewswire.com
ABBV | News | $167.89 0.89% 0.51% 3.6M
|
Health Technology
|
| O: -0.73%
H: 0.78%
C: 0.35%
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: -3.32%
H: 4.15%
C: -3.43%
biotechnologies financial results
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2023 THIRD QUARTER FINANCIAL RESULTS AND CONFERENCE CALL INFORMATION
Published: 2023-11-09 (Crawled : 15:00) - biospace.com/
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: -0.18%
H: 0.53%
C: -0.18%
conference biotechnologies financial results
CollPlant Biotechnologies Announces Patent Granted in U.S. for Photocurable Dermal Filler
Published: 2023-11-01 (Crawled : 11:00) - prnewswire.com
CLGN | $5.26 1.15% -0.19% 4.3K
|
Health Technology
|
| O: 0.19%
H: 23.88%
C: 23.88%
patent granted
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
CANG | $1.34 -4.29% 14.93% 120K
|
Technology Services
AZTR 4 | $0.195 13.85% 42K
|
n/a
TOVX | News | $0.411 -1.01% 12.9% 230K
|
Manufacturing
Last 48 Hours Insiders Buying
ETST P 79000 | $0.065 18.18% -67.14% 0
|
Manufacturing
|
11:30
MCFT P 26039 | $21.5 1.9% 1.86% 2.1K
|
Consumer Durables
|
00:00
YORW P 29 | $35.42 1.0% 1.02% 66K
|
Utilities
|
19:01
VUZI P 14500 | $1.35 11.57% 10.37% 840K
|
Electronic Technology
|
17:00
BANF P 256 | $91.28 2.24% 2.18% 150K
|
Finance
|
15:30
RMCF | $3.57 0.56% 0.28% 11K
|
Consumer Non-Durables
|
20:10